Exploring Novel Aptamer-Heparin Combinations to Improve Anticoagulation Therapy in Cardiopulmonary Bypass

被引：0
|
作者：
Chabata, Charlene V. [1 ]
Gunaratne, Ruwan [1 ]
Frederiksen, James W. [1 ]
Sullenger, Bruce A. [1 ]
机构：
[1] Duke Univ, Pharmacol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
784
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [41] Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity
    Manlhiot, Cedric
    Gruenwald, Colleen E.
    Holtby, Helen M.
    Brandao, Leonardo R.
    Chan, Anthony K.
    Van Arsdell, Glen S.
    McCrindle, Brian W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (02): : 444 - 450
  • [42] Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits
    Aldea, GS
    O'Gara, P
    Shapira, OM
    Treanor, P
    Osman, A
    Patalis, E
    Arkin, C
    Diamond, R
    Babikian, V
    Lazar, HL
    Shemin, RJ
    ANNALS OF THORACIC SURGERY, 1998, 65 (02): : 425 - 433
  • [43] Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran
    Kawada, Yu
    Katori, Nobuyuki
    Kaji, Keiko
    Fujioka, Shoko
    Yamaguchi, Tomoki
    JA CLINICAL REPORTS, 2024, 10 (01):
  • [44] Management of heparin resistance during cardiopulmonary bypass: The effect of five different anticoagulation strategies on hemostatic activation
    Koster, A
    Fischer, T
    Gruendel, M
    Mappes, A
    Kuebler, WM
    Bauer, M
    Kuppe, H
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2003, 17 (02) : 171 - 175
  • [45] Factors associated with errors in the heparin dose response test: recommendations to improve individualized heparin management in cardiopulmonary bypass
    Lee, Min-Ho
    Riley, William
    PERFUSION-UK, 2021, 36 (05): : 513 - 523
  • [46] MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME
    BERG, E
    STENBJERG, S
    ALBRECHTSEN, OK
    JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1979, 11 (06): : 229 - 235
  • [47] Monitoring heparin therapy during cardiopulmonary bypass and cardiac interventional catheterization in pediatrics
    El Rouby, S.
    Kim, G.
    Thompson, J.
    Williams, J.
    Jobes, D.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A199 - A199
  • [48] A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery
    Haselbach, Stephanie
    Maurer, Juergen
    Vogel, Vitali
    Harder, Sebastian
    Weber, Christian Friedrich
    Baykut, Doan
    Meininger, Dirk
    Keller, Harald
    Moritz, Anton
    Maentele, Werner
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (10) : 2037 - 2043
  • [49] Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect -: Anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin
    von Heymann, Christian
    Hagemeyer, Elmar
    Kastrup, Marc
    Ziemer, Sabine
    Proquitte, Hans
    Konertz, Wolfgang F.
    Spies, Claudia
    PEDIATRIC CRITICAL CARE MEDICINE, 2006, 7 (04) : 383 - 385
  • [50] REVERSAL OF HEPARIN ANTICOAGULATION BY RECOMBINANT PLATELET FACTOR-4 AND PROTAMINE SULFATE IN BABOONS DURING CARDIOPULMONARY BYPASS
    BERNABEI, A
    GIKAKIS, N
    MAIONE, TE
    KOWALSKA, MA
    YAN, Z
    NIEWIAROWSKI, S
    EDMUNDS, LH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (04): : 765 - 771
12345